InfuSystem Holdings Inc. reported net revenues of $36.5 million for the third quarter of 2025, representing a 3.0% increase from the prior year. Net income rose 25% to $2.3 million. Adjusted EBITDA (non-GAAP) was $8.3 million, up 6.0%, with an adjusted EBITDA margin of 23.0%, a 0.5% increase. Year-to-date net operating cash flow increased 38% to $17.3 million. Stock repurchases totaled $2.2 million during the quarter, and company liquidity was $54.6 million as of September 30, 2025. InfuSystem reaffirmed full-year 2025 guidance, projecting net revenue growth of 6% to 8% and an adjusted EBITDA margin of 20% or higher. The company advanced several initiatives aimed at profitable growth and cost reduction during the period.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InfuSystem Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-048516), on November 04, 2025, and is solely responsible for the information contained therein.